Temperature Affects Thrombolytic Efficacy Using rt-PA and Eptifibatide, an In Vitro Study

The potential for hypothermia as a neuroprotectant during stroke has led to its increase in clinical use. At the same time, combination pharmaceutical therapies for ischemic stroke using recombinant tissue plasminogen activator (rt-PA), and GP IIb-IIIa inhibitors, such as Eptifibatide (Epf ), are un...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Meunier, Jason M., Chang, Wan-Tsu W., Bluett, Brent, Wenker, Evan, Lindsell, Christopher J., Shaw, George J.
Format: Artigo
Sprache:Inglês
Veröffentlicht: Mary Ann Liebert, Inc. 2012
Schlagworte:
Original Articles
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3621317/
https://ncbi.nlm.nih.gov/pubmed/23667777
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/ther.2012.0007
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge